betamethasone 0.0005 MG/MG Topical Ointment
- RxCUI
- 197405
- RxNorm name
- betamethasone 0.0005 MG/MG Topical Ointment
- Display name
- Betamethasone (Topical)
- Full name
- betamethasone 0.0005 MG/MG Topical Ointment
- Term type
- SCD
- Status
- Active
- Strength
- 0.05%
- Dose form
- Ointment
- Route
- Topical
- Updated
- 2026-11-02 18:17:50
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| betamethasone dipropionate | 0.0005 MG / 1 MG | betamethasone | betamethasone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Ointment | 316985 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| betamethasone | 1514 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | betamethasone 0.0005 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Name | betamethasone 0.0005 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 11 linked values
| 11 | CODES |
| RxCUI | 197405 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0168-0056-15 | 0168-0056 | Betamethasone Dipropionate Betamethasone Dipropionate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA019141 |
| 0168-0056-46 | 0168-0056 | Betamethasone Dipropionate Betamethasone Dipropionate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | NDA019141 |
| 0472-0381-15 | 0472-0381 | Betamethasone Dipropionate Betamethasone Dipropionate | Actavis Pharma, Inc. | ANDA071012 |
| 0472-0381-45 | 0472-0381 | Betamethasone Dipropionate Betamethasone Dipropionate | Actavis Pharma, Inc. | ANDA071012 |
| 45802-505-14 | 45802-505 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Padagis Israel Pharmaceuticals Ltd | ANDA215847 |
| 45802-505-84 | 45802-505 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Padagis Israel Pharmaceuticals Ltd | ANDA215847 |
| 50090-0236-0 | 50090-0236 | Betamethasone Dipropionate Betamethasone Dipropionate | A-S Medication Solutions | NDA019141 |
| 52817-824-15 | 52817-824 | Betamethasone Dipropionate USP, 0.05% Betamethasone Dipropionate USP, 0.05% | TruPharma LLC | ANDA215186 |
| 52817-824-45 | 52817-824 | Betamethasone Dipropionate USP, 0.05% Betamethasone Dipropionate USP, 0.05% | TruPharma LLC | ANDA215186 |
| 63629-9323-1 | 63629-9323 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Bryant Ranch Prepack | ANDA215847 |
| 63629-9324-1 | 63629-9324 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Bryant Ranch Prepack | ANDA215847 |
| 70771-1550-1 | 70771-1550 | betamethasone dipropionate betamethasone dipropionate | Zydus Lifesciences Limited | ANDA214048 |
| 70771-1550-4 | 70771-1550 | betamethasone dipropionate betamethasone dipropionate | Zydus Lifesciences Limited | ANDA214048 |
| 71335-2715-1 | 71335-2715 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Bryant Ranch Prepack | ANDA215847 |
| 72162-1415-2 | 72162-1415 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Bryant Ranch Prepack | ANDA215847 |
| 72162-1415-4 | 72162-1415 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | Bryant Ranch Prepack | ANDA215847 |
| 72578-093-01 | 72578-093 | betamethasone dipropionate betamethasone dipropionate | Viona Pharmaceuticals Inc | ANDA214048 |
| 72578-093-06 | 72578-093 | betamethasone dipropionate betamethasone dipropionate | Viona Pharmaceuticals Inc | ANDA214048 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| NDA019141 | 0168-0056 | Betamethasone Dipropionate Betamethasone Dipropionate | NDA | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC |
| ANDA071012 | 0472-0381 | Betamethasone Dipropionate Betamethasone Dipropionate | ANDA | Actavis Pharma, Inc. |
| ANDA215847 | 45802-505 | BETAMETHASONE DIPROPIONATE betamethasone dipropionate | ANDA | Padagis Israel Pharmaceuticals Ltd |
| ANDA215186 | 52817-824 | Betamethasone Dipropionate USP, 0.05% Betamethasone Dipropionate USP, 0.05% | ANDA | TruPharma LLC |
| ANDA214048 | 70771-1550 | betamethasone dipropionate betamethasone dipropionate | ANDA | Zydus Lifesciences Limited |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1d40b962-5d97-4416-b46d-b0785acd261d | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 104 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20251021 |
| d6702ddc-4a1d-4d0d-bebd-bc615ed0bc35 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 104 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20240830 |
| 13196f0a-6daf-4f62-853c-ac2ac261ce43 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 101 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20250912 |
| 52c0e92f-986e-45e7-99cf-9a13ac386b1d | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 100 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20250728 |
| 7da1c732-3477-4031-b776-149bd5ceea27 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 24 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | 20230306 |
| 97dde5f5-a865-4af2-b562-8da72c8475f3 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 12 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | 20260128 |
| aa3f4012-7597-422d-8bcc-00102780a152 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 12 | Betamethasone Dipropionate Ointment , USP 0.05% (potency expressed as betamethasone) Rx only For Dermatologic Use Only – Not for Ophthalmic Use | 20230228 |
| dc35ba25-8746-4ed8-83c1-e6b6a1057863 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 5 | 20120103 | |
| 9adfb030-17c3-46eb-bf85-a90cabafd367 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 4 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20230807 |
| fc34987a-e803-4ac8-8a1e-9bdadd3f8b56 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 3 | Betamethasone Dipropionate Ointment USP, 0.05% | 20260118 |
| 0e56e8bc-b79e-43c6-945e-c333a599bfc8 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 3 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20240331 |
| f531da27-2435-49a3-8992-c65240c6a7fe | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 3 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | 20221105 |
| 82fd507e-927b-70e1-e053-2a91aa0ac903 | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 1 | 0262 BETAMETHASONE DIPRO OINT | 20190228 |
| 389cdebb-55fe-4808-a5b7-0f293d9ee45d | betamethasone dipropionate 0.05 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % Topical Ointment [SY] · betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment [SY] | 4 | 1 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% (potency expressed as betamethasone) For Dermatologic Use Only – Not for Ophthalmic Use Rx Only | 20100914 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 97dde5f5-a865-4af2-b562-8da72c8475f3 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 20260821 |
| 0173ed23-9f7c-466e-9eba-f6859d05f987 | Betamethasone Dipropionate Ointment USP, 0.05% | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | Salutas Pharma GmbH | 20260729 |
| 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE ointment (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 20260130 |
| 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE ointment (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 20260130 |
| 97dde5f5-a865-4af2-b562-8da72c8475f3 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 20260128 |
| 97dde5f5-a865-4af2-b562-8da72c8475f3 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 20260128 |
| fc34987a-e803-4ac8-8a1e-9bdadd3f8b56 | Betamethasone Dipropionate Ointment USP, 0.05% | TruPharma LLC | Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation. | 20260118 |
| 1d40b962-5d97-4416-b46d-b0785acd261d | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Bryant Ranch Prepack | 20251021 |
| 13196f0a-6daf-4f62-853c-ac2ac261ce43 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Bryant Ranch Prepack | 20250912 |
| 52c0e92f-986e-45e7-99cf-9a13ac386b1d | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Bryant Ranch Prepack | 20250728 |
| 853399f8-95a7-41f3-80e7-7ed8e3ff1a5e | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Ointment (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE ointment (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 20250708 |
| a8d9fa54-8715-4e03-ae27-17b26f97e23e | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (augmented). BETAMETHASONE DIPROPIONATE ointment, for topical use Initial U.S. Approval: 1983 | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 20250707 |
| d6702ddc-4a1d-4d0d-bebd-bc615ed0bc35 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Bryant Ranch Prepack | 20240830 |
| 0e56e8bc-b79e-43c6-945e-c333a599bfc8 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Padagis Israel Pharmaceuticals Ltd | 20240331 |
| 1d40b962-5d97-4416-b46d-b0785acd261d | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Bryant Ranch Prepack | 20240115 |
| f816ecef-66e2-4028-8a4e-1bc224e92597 | Betamethasone Dipropionate Ointment USP, 0.05% | Tasman Pharma Inc. | Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation. | 20231214 |
| 9adfb030-17c3-46eb-bf85-a90cabafd367 | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Viona Pharmaceuticals Inc | Zydus Lifesciences Limited | 20230807 |
| 7da1c732-3477-4031-b776-149bd5ceea27 | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | A-S Medication Solutions | 20230306 |
| aa3f4012-7597-422d-8bcc-00102780a152 | Betamethasone Dipropionate Ointment, USP 0.05% (potency expressed as betamethasone) Rx only For Dermatologic Use Only – Not for Ophthalmic Use | Actavis Pharma, Inc. | 20230228 |
| aa3f4012-7597-422d-8bcc-00102780a152 | Betamethasone Dipropionate Ointment , USP 0.05% (potency expressed as betamethasone) Rx only For Dermatologic Use Only – Not for Ophthalmic Use | Actavis Pharma, Inc. | 20230228 |
| af8317d7-b280-4f40-ad88-802f99d33d78 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (augmented). BETAMETHASONE DIPROPIONATE ointment (augmented) 0.05% for topical use Initial U.S. Approval: 1983 | Actavis Pharma, Inc. | 20230220 |
| af8317d7-b280-4f40-ad88-802f99d33d78 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (augmented). BETAMETHASONE DIPROPIONATE ointment (augmented) 0.05% for topical use Initial U.S. Approval: 1983 | Actavis Pharma, Inc. | 20230214 |
| f531da27-2435-49a3-8992-c65240c6a7fe | BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% | Zydus Lifesciences Limited | 20221105 |
| 30cd681b-7e50-4257-8235-547db94b030d | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT (augmented) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT (augmented). BETAMETHASONE DIPROPIONATE ointment (augmented) 0.05% for topical use Initial U.S. Approval: 1983 | Preferred Pharmaceuticals Inc. | 20220119 |
| b1b60231-b673-47ff-8217-d342d51164fc | These highlights do not include all the information needed to use DIPROLENE Ointment safely and effectively. See full prescribing information for DIPROLENE Ointment. DIPROLENE ® (augmented betamethasone dipropionate) ointment, for topical use Initial U.S. Approval: 1983 | Merck Sharp & Dohme Corp. | 20201207 |
| 82fd507e-927b-70e1-e053-2a91aa0ac903 | 0262 BETAMETHASONE DIPRO OINT | H.J. Harkins Company, Inc. | 20190228 |
| 6d931c6a-a2bd-45f9-9346-98dfe495239c | BETAMETHASONE DIPROPIONATE CREAM USP, 0.05% BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% BETAMETHASONE DIPROPIONATE LOTION USP, 0.05% | A-S Medication Solutions | 20190221 |
| 3e51766a-38bb-4ea9-ad43-1c4f9bc96f3e | National Council for Prescription Drug Programs | 20130213 | |
| 19716fea-f3b5-473d-a633-39018b316f12 | National Council for Prescription Drug Programs | 20130213 | |
| e0268e59-27bd-4650-ba14-63e8e97c92f8 | National Council for Prescription Drug Programs | 20130211 | |
| 049c6ec4-1cdb-4dcd-8844-428bae53322f | National Council for Prescription Drug Programs | 20130211 | |
| 8237286f-b4d5-4107-9294-1aaa9c483d65 | National Council for Prescription Drug Programs | 20120724 | |
| 7b2586db-4b90-4e4c-b574-9a9afc6a18bc | National Council for Prescription Drug Programs | 20120724 | |
| 6aaca9a3-2611-4892-95f1-1201eb95ad02 | National Council for Prescription Drug Programs | 20120724 | |
| 571d6be4-75b6-4af3-bb92-531af802ebdf | National Council for Prescription Drug Programs | 20120724 | |
| 2edab7bc-335d-4344-9cdc-23a00ee715b1 | National Council for Prescription Drug Programs | 20120724 | |
| cca348bb-28f4-4f19-997b-2268ecdbbdf2 | National Council for Prescription Drug Programs | 20120724 | |
| 17fe193d-a38d-433b-8c10-d63733c61368 | National Council for Prescription Drug Programs | 20120724 | |
| 13144d3a-b067-433c-9e61-bac839dcd6b8 | National Council for Prescription Drug Programs | 20120724 | |
| dc35ba25-8746-4ed8-83c1-e6b6a1057863 | Physicians Total Care, Inc. | 20120103 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S03BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S02BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | R01AD | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | betamethasone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | betamethasone | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | betamethasone | |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | betamethasone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | betamethasone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | betamethasone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | betamethasone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.0005 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA071012 |
| CODES | ANDA | ANDA214048 |
| CODES | ANDA | ANDA215186 |
| CODES | ANDA | ANDA215847 |
| CODES | NDA | NDA019141 |
| CODES | SNOMEDCT | 375669007 |
| CODES | VUID | 4005792 |
| NAMES | Prescribable Synonym | betamethasone dipropionate 0.05 % Topical Ointment |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |